Cannabinoid-induced relief of hypermotility in a rat model of the irritable bowel syndrome

Neurogastroenterol Motil. 2019 Jun;31(6):e13613. doi: 10.1111/nmo.13613.

Abstract

Cannabinoid-2 receptor agonists may be useful in treating intestinal motility disorders.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Animals
  • Cannabinoids*
  • Gastrointestinal Motility
  • Irritable Bowel Syndrome*
  • Rats
  • Receptors, Cannabinoid

Substances

  • Cannabinoids
  • Receptors, Cannabinoid